Literature DB >> 6615562

Leukapheresis in rheumatoid arthritis. Association of clinical improvement with reversal of anergy.

S M Wahl, R L Wilder, I M Katona, L M Wahl, J B Allen, I Scher, J L Decker.   

Abstract

In order to study the clinical and immunologic effects of a brief course of leukapheresis, 14 patients with clinically similar rheumatoid arthritis were segregated into 2 subgroups. Group A (7 patients) had subnormal lymphocyte tritiated thymidine incorporation to soluble antigens. After a brief course of leukapheresis, 6 of these 7 patients demonstrated substantial clinical improvement associated with significantly enhanced lymphocyte tritiated thymidine incorporation to soluble antigens. In contrast, none of the 7 patients in group B (normal immune functions) demonstrated similar changes in articular indices or lymphocyte proliferation. Thus, clinical improvement induced in a subset of rheumatoid arthritis patients appears to reflect modulation of function, and not simply immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6615562     DOI: 10.1002/art.1780260904

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  15 in total

1.  Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease.

Authors:  K Sawada; K Ohnishi; S Fukui; K Yamada; M Yamamura; K Amano; K Amano; M Wada; N Tanida; M Satomi
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

Review 2.  Cytokine therapy in rheumatoid arthritis.

Authors:  J Hermann; M Walmsley; F M Brennan
Journal:  Springer Semin Immunopathol       Date:  1998

3.  Spontaneous lymphocyte activity in rheumatoid arthritis in a longitudinal study in relation to gold therapy.

Authors:  K S Froebel; D Lewis; R Dickson; R D Sturrock
Journal:  Clin Rheumatol       Date:  1985-09       Impact factor: 2.980

Review 4.  Lymphocyte traffic, endothelium, and rheumatoid arthritis.

Authors:  D Haskard
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

5.  Flare-up of antigen-induced arthritis in mice after challenge with intravenous antigen: effects of pre-treatment with cobra venom factor and anti-lymphocyte serum.

Authors:  J W Lens; W B van den Berg; L B van de Putte; J H Berden; S P Lems
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

Review 6.  Dendritic cells in the pathogenesis of rheumatoid arthritis.

Authors:  L M March
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

7.  Absence of peripheral blood T cell responses to "shared epitope' containing peptides in recent onset rheumatoid arthritis.

Authors:  G J McColl; J Hammer; L C Harrison
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

8.  Immunotherapy of collagen-induced arthritis by a T-cell antiproliferative molecule.

Authors:  D J Spannaus-Martin; R Holmdahl; T F Kresina
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

9.  Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics.

Authors:  D G Malone; S M Wahl; M Tsokos; H Cattell; J L Decker; R L Wilder
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

10.  Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.

Authors:  G Hahn; B Stuhlmüller; N Hain; J R Kalden; K Pfizenmaier; G R Burmester
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.